Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
- 1 July 2002
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 36 (1) , 150-155
- https://doi.org/10.1053/jhep.2002.33713
Abstract
Recently, several epidemiologic observations have suggested that obesity might be an independent risk factor for certain malignancies such as breast cancer, colon cancer, renal cell carcinoma, and esophageal adenocarcinoma. However, there are no studies examining the risk of hepatocellular carcinoma (HCC) in obesity. The aim of the present study was to determine whether obesity is an independent risk factor for HCC in patients with cirrhosis. Explanted liver specimens from a national database on patients undergoing liver transplantation were examined for HCC, and the incidence was compared among patients with varying body mass indices according to the etiology of cirrhosis. A multivariate analysis was used for controlling other potentially confounding variables such as age and sex. Among 19,271 evaluable patients, the overall incidence of HCC was 3.4% (n = 659) with a slightly higher prevalence among obese patients compared with lean patients. Obesity was an independent predictor for HCC in patients with alcoholic cirrhosis (odds ratio [OR], 3.2; 95% CI, 1.5-6.6; P = .002) and cryptogenic cirrhosis (OR, 11.1; 95% CI, 1.5-87.4; P = .02). Obesity was not an independent predictor in patients with hepatitis C, hepatitis B, primary biliary cirrhosis, and autoimmune hepatitis. The higher risk of HCC in obese patients is confined to alcoholic liver disease and cryptogenic cirrhosis. In conclusion, more frequent surveillance for HCC may be warranted in obese patients with alcoholic and cryptogenic cirrhosis. However, as this study is based on patients with advanced cirrhosis, our findings need to be confirmed in a broader population of individuals with cirrhosis.Keywords
This publication has 29 references indexed in Scilit:
- Peroxisomal β-Oxidation and SteatohepatitisSeminars in Liver Disease, 2001
- Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinomaOncogene, 2000
- Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying DiseaseHepatology, 1999
- List of contributorsEuropean Journal Of Cancer Prevention, 1998
- Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative studyHepatology, 1997
- Hepatocarcinogenesis in woodchuck hepatitis virus/c- myc mice: Sustained cell proliferation and biphasic activation of insulin-like growth factor IIHepatology, 1997
- Excess Risk of Primary Liver Cancer in Patients With Diabetes MellitusJNCI Journal of the National Cancer Institute, 1996
- Sex Differences in Insulin Levels in Older Adults and the Effect of Body Size, Estrogen Replacement Therapy, and Glucose Tolerance Status: The Rancho Bernardo Study, 1984–1987Diabetes Care, 1995
- Nonviral Risk Factors for Hepatocellular Carcinoma in a Low-Risk Population, the Non-Asians of Los Angeles County, CaliforniaJNCI Journal of the National Cancer Institute, 1991
- Estrogen Induction of Hepatocellular Carcinomas in Armenian HamstersHepatology, 1990